S80080
具體成交價(jià)以合同協(xié)議為準(zhǔn)
- 公司名稱 上海源葉生物科技有限公司
- 品牌
- 型號(hào)
- 產(chǎn)地
- 廠商性質(zhì) 生產(chǎn)廠家
- 更新時(shí)間 2025/5/15 20:55:11
- 訪問次數(shù) 183
聯(lián)系方式:何小姐15921386130 查看聯(lián)系方式
聯(lián)系我們時(shí)請(qǐng)說明是化工儀器網(wǎng)上看到的信息,謝謝!
- 產(chǎn)品描述: Mizolastine is an orally active, high affinity and specific peripheral histamine H1 receptor antagonist (second generation antihistamine). Mizolastine effectively inhibits mRNA expression of VEGF165, VEGF120, TNF-α and KC. Mizolastine can be used in studies of allergic rhinitis and chronic idiopathic urticarial
- 靶點(diǎn): Histamine Receptor
- 體內(nèi)研究: Mizolastine (0.3 mg/kg; p.o.; single daily for 7 days) inhibits production of 5-LOX AA (arachidonic acid) metabolite leukotriene B4 (LTB4), and suppresses expression of 5-LOX, cytosolic PLA2 (cPLA2), 5-LOX-activating protein, and LTB4 receptor mRNA in the AA-induced inflammation model
- 參考文獻(xiàn):
1. Xia Q, et al. The effect of mizolastine on expression of vascular endothelial cell growth factor, tumour necrosis factor-alpha and keratinocyte-derived chemokine in murine mast cells, compared with dexamethasone and loratadine. Clin Exp Dermatol. 2005 Mar 2. Ren X, et al. The anti-inflammatory effects of Yunnan Baiyao are involved in regulation of the phospholipase A2/arachidonic acid metabolites pathways in acute inflammation rat model. Mol Med Rep. 2017 Oct;16(4):4045-4053. 3. Prakash A, et al. Mizolastine: a review of its use in allergic rhinitis and chronic idiopathic urticaria. BioDrugs. 1998 Jul;10(1):41-63.
- 溶解度: DMSO : 25 mg/mL (57.80 mM; Need ultrasonic) H2O : 1 mg/mL (2.31 mM; ultrasonic and warming and heat to 80°C)
- 保存條件: -20℃
- 配置溶液濃度參考:
1mg 5mg 10mg 1 mM 2.312 ml 11.561 ml 23.122 ml 5 mM 0.462 ml 2.312 ml 4.624 ml 10 mM 0.231 ml 1.156 ml 2.312 ml 50 mM 0.046 ml 0.231 ml 0.462 ml
- 注意:部分產(chǎn)品我司僅能提供部分信息,,我司不保證所提供信息的性,,僅供客戶參考交流研究之用,。